Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed

BACKGROUND: Pemetrexed is widely used for the treatment of advanced non-squamous non-small-cell lung cancer (NSCLC). However, factors that can predict the benefits of pemetrexed therapy have not yet been defined. METHODS: We compared the clinical and molecule pathological characteristics of good and...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sojung, Kim, Hyun Jung, Choi, Chang–Min, Lee, Dae Ho, Kim, Sang–We, Lee, Jung–Shin, Kim, Woo Sung, Choi, Se Hoon, Rho, Jin Kyung, Lee, Jae Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936194/
https://www.ncbi.nlm.nih.gov/pubmed/27388008
http://dx.doi.org/10.1186/s12885-016-2457-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936194/
https://www.ncbi.nlm.nih.gov/pubmed/27388008
http://dx.doi.org/10.1186/s12885-016-2457-0

Ejemplares similares